Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guislaine Carcelain

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Medical Virology|October 20, 2012
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropismCathia Soulié, Charlotte Charpentier, Philippe Flandre, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2024
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trialMaxime Beaulieu, Alexandre Gaymard, Clément Massonnaud, et al.
AIDS (London, England)|March 28, 2003
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopeniaGuislaine Carcelain, Pierre Saint-Mézard, Hester Korthals Altes, et al.
Antiviral Therapy|May 17, 2007
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, MaliAnne Derache, Ousmane Traore, Victoria Koita, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Journal of Immunological Methods|June 21, 2024
Strategies to determine positive anti-SARS-CoV-2 memory T lymphocyte response during the evolution of an epidemicIsabelle Nel, Ajeeva Ithayakumar, Noémie Blumenthal, et al.
Nephron. Physiology|March 25, 2006
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART eraCorinne Isnard Bagnis, Sophie Tezenas Du Montcel, Michele Fonfrede, et al.
Plos One|July 27, 2007
Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progressionFanny Mochel, Perrine Charles, François Seguin, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapyXavier Mariette, Gabriel Baron, Florence Tubach, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Medical Virology|October 20, 2012
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropismCathia Soulié, Charlotte Charpentier, Philippe Flandre, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2024
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trialMaxime Beaulieu, Alexandre Gaymard, Clément Massonnaud, et al.
AIDS (London, England)|March 28, 2003
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopeniaGuislaine Carcelain, Pierre Saint-Mézard, Hester Korthals Altes, et al.
Antiviral Therapy|May 17, 2007
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, MaliAnne Derache, Ousmane Traore, Victoria Koita, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Journal of Immunological Methods|June 21, 2024
Strategies to determine positive anti-SARS-CoV-2 memory T lymphocyte response during the evolution of an epidemicIsabelle Nel, Ajeeva Ithayakumar, Noémie Blumenthal, et al.
Nephron. Physiology|March 25, 2006
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART eraCorinne Isnard Bagnis, Sophie Tezenas Du Montcel, Michele Fonfrede, et al.
Plos One|July 27, 2007
Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progressionFanny Mochel, Perrine Charles, François Seguin, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapyXavier Mariette, Gabriel Baron, Florence Tubach, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Pageof 8